159 related articles for article (PubMed ID: 4552443)
1. [Evaluation of L-DOPA in Parkinsonism with special reference to the study by double-blind method].
Okajima T; Kubota A; Nakahara N; Takeda S; Shimomura K
Naika; 1972; 29(2):335-43. PubMed ID: 4552443
[No Abstract] [Full Text] [Related]
2. [L-Dopa therapy in Parkinson's disease. A double-blind study].
Worm-Petersen J; Dupont E; Mikkelsen B
Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
[No Abstract] [Full Text] [Related]
3. [Levodopa and Parkinsonism. A double-blind study].
Pakkenberg H; Dupont E; Garde B; Hansen E; Melsen S; Vestberg F
Ugeskr Laeger; 1971 Nov; 133(46):2275-9. PubMed ID: 4944650
[No Abstract] [Full Text] [Related]
4. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor].
Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Zamponi A
Minerva Med; 1972 Dec; 63(89):4853-61. PubMed ID: 4566743
[No Abstract] [Full Text] [Related]
5. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.
Yahr MD; Duvoisin RC; Hoehn MM; Schear MJ; Barrett RE
Trans Am Neurol Assoc; 1968; 93():56-63. PubMed ID: 4885744
[No Abstract] [Full Text] [Related]
6. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
[No Abstract] [Full Text] [Related]
7. [Use of L-DOPA in the therapy of parkinsonism].
D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G
Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734
[No Abstract] [Full Text] [Related]
8. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
Sugita K; Mutsuga N; Takaoka Y; Takeda A
No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927
[No Abstract] [Full Text] [Related]
9. [Analysis of the effects of L-dopa during a 3-month course of treatment].
Pinto F; Venturini E
Riv Neurobiol; 1970; 16(4):415-28. PubMed ID: 4949926
[No Abstract] [Full Text] [Related]
10. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
Stammler A; Vielhaber K
Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct; 40(10):564-8. PubMed ID: 4565521
[No Abstract] [Full Text] [Related]
11. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
Uono M; Tanabe H; Yano Y; Nakao K
No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082
[No Abstract] [Full Text] [Related]
12. [Treatment of Parkinson's disease with L-dopa. 77 cases].
Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
[No Abstract] [Full Text] [Related]
13. L-dopa in the treatment of Parkinsonism.
Brezný I; Buranová D; Cernácek J; Trávniková M
Act Nerv Super (Praha); 1972; 14(2):96. PubMed ID: 5040182
[No Abstract] [Full Text] [Related]
14. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
Muenter MD
Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343
[No Abstract] [Full Text] [Related]
15. Parkinsonism and DOPA.
Cotzias GC; Papavasiliou PS; Gellene R; Aronson RB
Trans Assoc Am Physicians; 1968; 81():171-83. PubMed ID: 4889342
[No Abstract] [Full Text] [Related]
16. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
17. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
Mones RJ; Elizan TS
J Mt Sinai Hosp N Y; 1969; 36(6):503-15. PubMed ID: 5261089
[No Abstract] [Full Text] [Related]
18. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
Herskovits E; Matera R; Gacitua EF
Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
[No Abstract] [Full Text] [Related]
19. A double-blind controlled study of MK-486 in Parkinson's disease.
Schwartz AM; Olanow CW; Spencer A
Trans Am Neurol Assoc; 1973; 98():301-3. PubMed ID: 4594189
[No Abstract] [Full Text] [Related]
20. [L-dopa in the treatment of parkinsonism].
Goldsztajn M; Reichowa J
Przegl Lek; 1971 Sep; 27(9):592-3. PubMed ID: 4942580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
